Table 2.
Cell Analyzed | Direction of Change Compared to Control |
p Value |
---|---|---|
Bone Marrow EPCs | ||
SCA-1+/VEGF-R2+/CD45− | Increase in number | 0.006 |
SCA-1+/VEGF-R2+/CD45+ | Increase in number | 0.009 |
SCA-1+/VEGF-R2+ | Increase in number | 0.006 |
Circulating EPCs | ||
SCA-1+/VEGF-R2+/CD45− | Increase in number | 0.038 |
SCA-1+/VEGF-R2+/CD45+ | Increase in number | 0.00005 |
SCA-1+/VEGF-R2+ | Increase in number | 0.00009 |
Circulating Endothelial Cells | ||
CD31+/CD146+ | Increase in number | 0.0004 |
Endothelial Microparticles | ||
CD31+/CD146+ | -- | 0.758 |
-- denotes no significant directional change